Zymeworks

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zymeworks and other ETFs, options, and stocks.

About ZYME

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2).

CEO

Kenneth Harry Galbraith

CEOKenneth Harry Galbraith

Employees

277

Employees277

Headquarters

Middletown, Delaware

HeadquartersMiddletown, Delaware

Founded

2003

Founded2003

Employees

277

Employees277

ZYME Key Statistics

Market cap

1.01B

Market cap1.01B

Price-Earnings ratio

-9.65

Price-Earnings ratio-9.65

Dividend yield

—

Dividend yield—

Average volume

546.57K

Average volume546.57K

High today

$14.76

High today$14.76

Low today

$14.43

Low today$14.43

Open price

$14.67

Open price$14.67

Volume

362.66K

Volume362.66K

52 Week high

$17.70

52 Week high$17.70

52 Week low

$7.97

52 Week low$7.97

Analyst ratings

50%

of 6 ratings

Buy

50%

Hold

50%

Sell